Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma

Journal of Neurosurgery

Volumn 105, Issue 1, 2006, Pages 34-40

  Keles, G Evren ^a   Chang, Edward F ^a   Lamborn, Kathleen R ^a   Tihan, Tarik ^a   Chang, Chih Ju ^a   Chang, Susan M ^a   Berger, Mitchel S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anaplastic astrocytoma; Extent of resection; Prognosis; Survival; Volumetric measurement

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33745548155     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2006.105.1.34     Document Type: Article

References (26)

1. Berger MS, Deliganis AV, Dobbins J, Keles GE: The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74:1784-1791, 1994
2. Chamberlain MC, Murovic JA, Levin VA: Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 38:1371-1374, 1988
3. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Nelson DF, et al: Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol 12:219-227, 1992
4. Daumas-Duport C, Tucker ML, Kolles H, Cervera P, Beuvon F, Varlet P, et al: Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria. J Neurooncol 34:61-78, 1997
5. Donahue B, Scott CB, Nelson JS, Rotman M, Murray KJ, Nelson DF, et al: Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. Int J Radiat Oncol Biol Phys 38:911-914, 1997
6. Duong DH, Rostomily RC, Haynor DR, Keles GE, Berger MS: Measurement of tumor resection volumes from computerized images. Technical note. J Neurosurg 77:151-154, 1992
7. Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF: The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 49:436-440, 1998
8. Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42:227-231, 1999
9. Keles GE, Anderson B, Berger MS: The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 52:371-379, 1999
10. Keles GE, Lamborn KR, Berger MS: Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735-745, 2001
11. Keles GE, Lamborn KR, Chang SM, Prados MD, Berger MS: Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastoma multiforme who are undergoing chemotherapy. J Neurosurg 100:41-46, 2004
12. Keles GE, Lundin DA, Lamborn KR, Chang EF, Ojemann G, Berger MS: Intraoperative subcortical stimulation mapping for hemispheric perirolandic gliomas located within or adjacent to the descending motor pathways: evaluation of morbidity and assessment of functional outcome in 294 patients. J Neurosurg 100:369-375, 2004
13. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3:255-268, 1993
14. Kondziolka D, Lunsford LD, Martinez AJ: Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79:533-536, 1993
15. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001
16. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, et al: Glioma Outcomes Investigators: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99:467-473, 2003
17. Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR IV, et al: Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 25:214-221, 2004
18. Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73:331-344, 1990
19. Nitta T, Sato K: Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75:2727-2731, 1995
20. Oh J, Henry RG, Pirzkall A, Lu Y, Li X, Catalaa I, et al: Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 19:546-554, 2004
21. Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, et al: European Organization for Research and Treatment of Cancer Brain Tumor Cooperative Group; European Organization for Research and Treatment of Cancer Radiotherapy Cooperative Group: Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076-2084, 2002
22. Pirzkall A, McKnight TR, Graves EE, Carol MP, Sneed PK, Wara WW, et al: MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50:915-928, 2001
23. Scott JN, Brasher PMA, Sevick RJ, Rewcastle NB, Forsyth PA: How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59:947-949, 2002
24. Shibamoto Y, Yamashita J, Takahashi M, Yamasaki T, Kikuchi H, Abe M: Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases. Radiother Oncol 18:9-17, 1990
25. Tortosa A, Vinolas N, Villa S, Verger E, Gil JM, Brell M, et al: Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas. Cancer 97:1063-1071, 2003
26. Wong ET, Jackson EF, Hess KR, Schomer DF, Hazle JD, Kyritsis AP, et al: Correlation between dynamic MRI and outcome in patients with malignant gliomas. Neurology 50:777-781, 1998